Non-invasive telemedical care in heart failure patients and stroke: post hoc analysis of TIM-HF and TIM-HF2 trials

被引:4
作者
Tuetuencue, Serdar [1 ]
Honold, Marcus
Koehler, Kerstin [2 ]
Deckwart, Oliver [2 ]
Koehler, Friedrich [2 ]
Haeusler, Karl Georg [3 ]
机构
[1] Charite Univ Med Berlin, Ctr Stroke Res Berlin, Hindenburgdamm 30, D-12200 Berlin, Germany
[2] Charite Univ Med Berlin, Dept Cardiol & Angiol, Ctr Cardiovasc Telemed, Campus Mitte, Berlin, Germany
[3] Univ Klinikum Wurzburg, Dept Neurol, Wurzburg, Germany
来源
ESC HEART FAILURE | 2020年 / 7卷 / 03期
关键词
Ischaemic stroke; Chronic heart failure; Telemedical Interventional Management in Heart Failure; ATRIAL-FIBRILLATION; AMBULATORY PATIENTS; ISCHEMIC-STROKE; RISK; MORTALITY; IMPACT;
D O I
10.1002/ehf2.12679
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims Patients with chronic heart failure (CHF) have an increased risk of ischaemic stroke. We aimed to identify the incidence rate and factors associated with ischaemic stroke or transient ischaemic attack (TIA) in CHF patients as well as the impact of non-invasive telemedical care (NITC) on acute stroke/TIA. Methods and results We retrospectively analysed baseline characteristics of 2248 CHF patients enrolled to the prospective multicentre Telemedical Interventional Monitoring in Heart Failure study (TIM-HF) and Telemedical Interventional Management in Heart Failure II study (TIM-HF2), randomizing New York Heart Association (NYHA) II/III patients 1:1 to NITC or standard of care. Hospitalizations due to acute ischaemic stroke or TIA during a follow-up of 12 months were analysed. Old age, hyperlipidaemia, lower body mass index, and peripheral arterial occlusive disease (PAOD) were independently associated with present cerebrovascular disease on enrolment. The stroke/TIA rate was 1.5 per 100 patients-years within 12 months after randomization (n = 32, 1.4%). Rate of stroke/TIA within 12 months was in the intervention group similar compared with the control group (50.0% vs. 49.8%; P = 0.98) despite that the rate of newly detected atrial fibrillation (AF) was higher in the intervention group (14.1% vs. 1.6%; P < 0.001). A history of PAOD (OR 2.7, 95% CI 1.2-6.2; P = 0.02) and the highest tertile (OR 3.0, 95% CI 1.1-8.3) of N-terminal pro-brain natriuretic peptide (NT-proBNP) on enrolment were associated with stroke/TIA during follow-up. In patients who suffered acute stroke or TIA during follow-up, echocardiography was part of the diagnostic workup in only 56% after hospital admission. Conclusions Annual rate of ischaemic stroke/TIA in NYHA II/III patients is low but higher in those with elevated NT-proBNP levels and history of PAOD at baseline. NITC showed no impact on the stroke rate during 1 year follow-up despite a significantly higher rate of newly detected AF. Irrespective of known CHF, echocardiography was often missing during in-hospital diagnostic workup after acute stroke/TIA.
引用
收藏
页码:884 / 891
页数:8
相关论文
共 24 条
  • [21] Prognostic impact of elevated serum uric acid levels on long-term outcomes in patients with chronic heart failure: A post-hoc analysis of the GISSI-HF (Gruppo Italiano per lo Studio della Sopravvivenza nella Insufficienza Cardiaca-Heart Failure) trial
    Mantovani, Alessandro
    Targher, Giovanni
    Temporelli, Pier Luigi
    Lucci, Donata
    Gonzini, Lucio
    Nicolosi, Gian Luigi
    Marchioli, Roberto
    Tognoni, Gianni
    Latini, Roberto
    Cosmi, Franco
    Tavazzi, Luigi
    Maggioni, Aldo Pietro
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2018, 83 : 205 - 215
  • [22] SGLT2 inhibitors in patients with heart failure with reduced ejection fraction: a meta-analysis of the EMPEROR-Reduced and DAPA-HF trials
    Zannad, Faiez
    Ferreira, Joao Pedro
    Pocock, Stuart J.
    Anker, Stefan D.
    Butler, Javed
    Filippatos, Gerasimos
    Brueckmann, Martina
    Ofstad, Anne Pernille
    Pfarr, Egon
    Jamal, Waheed
    Packer, Milton
    LANCET, 2020, 396 (10254) : 819 - 829
  • [23] Risk of Stroke in Chronic Heart Failure Patients Without Atrial Fibrillation Analysis of the Controlled Rosuvastatin in Multinational Trial Heart Failure (CORONA) and the Gruppo Italiano per lo Studio della Sopravvivenza nell'Insufficienza Cardiaca-Heart Failure (GISSI-HF) Trials
    Abdul-Rahim, Azmil H.
    Perez, Ana-Cristina
    Fulton, Rachael L.
    Jhund, Pardeep S.
    Latini, Roberto
    Tognoni, Gianni
    Wikstrand, John
    Kjekshus, John
    Lip, Gregory Y. H.
    Maggioni, Aldo P.
    Tavazzi, Luigi
    Lees, Kennedy R.
    McMurray, John J. V.
    CIRCULATION, 2015, 131 (17) : 1486 - 1494
  • [24] Dapagliflozin and new-onset type 2 diabetes in patients with chronic kidney disease or heart failure: pooled analysis of the DAPA-CKD and DAPA-HF trials
    Rossing, Peter
    Inzucchi, Silvio E.
    Vart, Priya
    Jongs, Niels
    Docherty, Kieran F.
    Jhund, Pardeep S.
    Kober, Lars
    Kosiborod, Mikhail N.
    Martinez, Felipe A.
    Ponikowski, Piotr
    Sabatine, Marc S.
    Solomon, Scott D.
    DeMets, David L.
    Bengtsson, Olof
    Lindberg, Magnus
    Langkilde, Anna Maria
    Sjostrand, Mikaela
    Stefansson, Bergur, V
    Karlsson, Cecilia
    Chertow, Glenn M.
    Hou, Fan Fan
    Correa-Rotter, Ricardo
    Toto, Robert D.
    Wheeler, David C.
    McMurray, John J., V
    Heerspink, Hiddo J. L.
    LANCET DIABETES & ENDOCRINOLOGY, 2022, 10 (01) : 24 - 34